Here is the meat of the release
"
Melbourne, Australia and Princeton, NJ, June 3, 2024 -- O
pthea Limited (ASX/NASDAQ:
OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing
novel therapies to treat highly prevalent and progressive retinal diseases, including wet
age-related macular degeneration (wet AMD), today announced that the Company will
make several presentations at the Clinical Trials at the Summit (CTS) Meeting being held
in Park City, Utah on June 8, 2024. Frederic Guerard, PharmD, Chief Executive Officer
of Opthea, will participate in a panel, there will be two scientific presentations related to
the sozinibercept (OPT-302) clinical trial program and a sponsor talk.
CTS brings together experts from around the world to discuss ongoing clinical trials and
the latest data with the goal of accelerating advances in vitreoretinal care.
Opthea Presentations (in program order):
Session: Clinical Trials Addressing Neovascular AMD (nAMD)
Scientific Presentation: Implications for Targeting VEGF-C/D: Potential for Vision Gain
Beyond VEGF-A Inhibition
Time: 1:02 - 1:06 pm MDT
Presenter: Megan Baldwin, PhD, MAICD, Founder, Chief Innovation Officer and Executive Director, Opthea
Scientific Presentation: Superior Functional Outcomes Beyond Standard of
Care: Update on Sozinibercept Clinical Trials
Time: 1:06 - 1:10 pm MDT
Presenter: Julie Clark, MD, Senior Vice President of Clinical Development, Opthea
Sponsor Talk: Opthea Overview
Time: 1:39 – 1:49 pm MDT
Panel: Challenges of Bringing New Treatment Options to Market
Time: 3:40 - 4:00 pm MDT
Panelist: Frederic Guerard, PharmD, Chief Executive Officer, Opthea
"
Anyone got any experience with the type of new info discussed and to why it is price sensistive ? My question is, given that the topline results won't be released until at least this time in 2025, could this presentation include interim results, safety updates, or early efficacy signals that provide any clues on June 8 (9th Australian time) ?
- Forums
- ASX - By Stock
- Ann: Opthea to Present at Clinical Trials at the Summit Meeting
Here is the meat of the release"Melbourne, Australia and...
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
66.0¢ |
Change
0.030(4.76%) |
Mkt cap ! $812.5M |
Open | High | Low | Value | Volume |
62.0¢ | 67.5¢ | 62.0¢ | $2.533M | 3.887M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 14912 | 66.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
67.0¢ | 19820 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 14912 | 0.660 |
1 | 27404 | 0.655 |
4 | 82704 | 0.650 |
1 | 27404 | 0.645 |
3 | 58653 | 0.640 |
Price($) | Vol. | No. |
---|---|---|
0.670 | 19820 | 2 |
0.675 | 45076 | 3 |
0.680 | 78154 | 3 |
0.685 | 69430 | 2 |
0.690 | 36440 | 3 |
Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |